The Oncology Institute, Inc. (TOI)
NCM · Healthcare · Medical Care Facilities
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 119.8M | 136.6M | 142.0M | 147.4M |
| Gross Profit | 17.5M | 18.9M | 22.8M | 23.3M |
| Operating Income | -11.2M | -8.1M | -6.9M | -6.5M |
| Net Income | -17.0M | -16.5M | -7.5M | -2.5M |
| Diluted EPS | $-0.15 | $-0.14 | $-0.06 | $-0.02 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 252.5M | 324.2M | 393.4M | 502.7M |
| Gross Profit | 52.1M | 59.6M | 54.0M | 76.4M |
| Operating Income | -72.0M | -60.2M | -60.1M | -36.1M |
| Net Income | 152K | -83.1M | -64.7M | -60.6M |
| Diluted EPS | $-0.20 | $-0.92 | $-0.71 | $nan |